Implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) devices have been shown to improve outcomes in select patients with heart failure with reduced ejection fraction and constitute one of the pillars of guideline-directed therapy.
| INTRODUC TI ON
Implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) devices have been shown to improve outcomes in select patients with heart failure with reduced ejection fraction and constitute one of the pillars of guideline-directed therapy. 1 Heart transplantation is an accepted treatment option for stage D heart failure, and more than 4000 heart transplants are performed each year worldwide. 2 In patients undergoing heart transplantation, cardiovascular implantable electronic devices (CIEDs) are generally extracted. Nevertheless, sometimes complete extraction is not possible and ICD coils or lead fragments are left behind. [3] [4] [5] [6] [7] [8] The purpose of our study was to evaluate the prevalence of retained CIED fragments in patients undergoing heart transplantation at our institution, and to identify risk factors and associated complications.
We performed a retrospective review of 402 consecutive patients who underwent infection after adjusting for potential confounders. In summary, retained CIED fragments are common after heart transplantation, and are associated with longer radiation exposure during biopsy procedures and upper extremity deep venous thrombosis.
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| Patient population
All adult patients who underwent heart transplantation at The 
| Surgical technique
At the time of transplantation, although the recipient is under cardiopulmonary bypass, the leads are divided at the level of the superior vena cava. Once the heart is implanted and protamine has been administered, the device pocket is opened and the leads are extracted by pulling on the leads. Our policy is to extract CIED completely if feasible. If severe coagulopathy is present or if the leads are not freely mobile, the surgeon may decide to resect as much of the leads as possible.
| Outcomes
Adverse events and outcomes after transplantation were evaluated 
| RE SULTS
Four hundred and two patients underwent heart transplantation during the study period. After exclusion criteria were met, 386 patients were included in the present analysis ( Figure 1 ). Table 1 (16.2%) had a retained fragment after heart transplantation. Compared to patients without retained lead fragments, those with retained fragments were older, with a higher body surface area and higher prevalence of diabetes mellitus. In addition, at the time of transplantation, these patients had leads with longer dwell times, more active leads, as well as higher prevalence of abandoned leads and dual-coil defibrillator leads ( Table 2 ). The most frequent location of retained lead fragments was the left brachiocephalic trunk. The ICD coil was the most frequent identified fragment, and most of fragments were ≥40 mm (Table S1 ).
Examples of retained CIED fragments are shown in Figure 2 .
| Radiation exposure
CIED fragment retention and location was evaluated with respect to subsequent radiation exposure during endomyocardial biopsy. A total of 4083 isolated endomyocardial biopsy procedures were performed transplantation. Because 2 patients had retained CIED fragments removed after transplantation, subsequent biopsy studies in these patients were excluded from analysis. Total radiation dose and skin dose were lower in patients who never had a CIED versus patients who previously had a CIED (both P < .001). In patients with a prior CIED, radiation dose and skin dose were similar if the fragment was in a non-SVC location, whereas fluoroscopy time was slightly longer.
However, in patients with a retained fragment in the SVC, there was significantly higher total radiation dose, skin dose, and fluoroscopy time during biopsy procedures (Table 3) . Regression analysis demonstrated a significant association between presence of a retained SVC fragment and total radiation dose (P = .001), skin dose (P ≤ .001), and fluoroscopy time (P = .016) after adjusting for length of time since transplantation.
| Magnetic resonance imaging
A total of 5 patients (10.2%) with retained CIED fragments were exposed to MRI compared to 55 (21.8%) in the group of patients without retained lead fragments (P = .078). No MRI-related complications were reported (Tables S2 and S3 ).
| Adverse events
All patients were followed for adverse events. The median follow-up was 3.2 years per patient. Cumulative events are shown in Table 4 .
Survival analysis was then performed with an endpoint of time to upper extremity DVT with death as a competing risk. The mortality was not significantly different in patients with pretransplant CIED with and without fragments (12% vs 11%, P = .81). TA B L E 2 Baseline device characteristics in patients with pretransplant cardiovascular implantable electronic device Figure 3 shows Kaplan-Meier curves by presence of retained CIED in all patients who underwent heart transplantation. A retained CIED fragment was associated with an increased risk of upper extremity DVT (log-rank P = .003, Figure 3A ). Patients with a retained CIED fragment were not at a higher risk of subsequent bloodstream infections (log-rank P = .622, Figure 3B ).
The characteristics of the bloodstream infections in all patients
included in the study are shown in Table S4 . Two patients (4%) required removal of the retained fragments because of bacteremia.
A transvenous extraction approach was performed in both patients, with one patient requiring resection and reconstruction of innominate vein and SVC to control the infection
| D ISCUSS I ON
In this retrospective study of patients undergoing heart transplantation at our institution, we describe the frequency and subsequent complications of retained CIED fragments. The overall incidence was 16.2%, which is on the lower end of prevalence as compared to prior reports (16.1-47.5%). There have been few prior analyses of CIED leads in heart transplant patients. It is known that lead types as well as a longer interval between device implant and transplant are associated with retained CIED fragments. 4, 7 The presence of increased frequency of abandoned leads reported in our study deserves further evaluation. Although abandoned leads have been reported to complicate the management of device infections, 9 to our knowledge this is the first report addressing the frequency and implications with regard to retained CIED fragments.
Infection remains the second most common cause of death in patients after heart transplantation. 2 Specifically, bloodstream infections are not infrequent in this population treated with immunosuppression, and are associated with a poor prognosis. 10, 11 Infection requiring extraction of CIED fragments in transplant patients has been reported rarely in the literature. 12 There was a numerical higher percent of bloodstream infections in patients with a retained fragment, although this was not statistically significant. However, there were 2 patients who required fragment extraction for bloodstream infection (one of which required open surgical extraction).
The overall incidence of DVT in heart transplant patients has been estimated to be 9.3%, with almost half of the cases being due to upper extremity DVT. 13 The presence of retained CIED fragments was postulated as a risk factor for upper extremity DVT based on a preliminary report, 6 and our findings confirm this.
The lower incidence of MRI use in the patients with retained fragments suggests that clinicians may have avoided MRI in these F I G U R E 3 Kaplan-Meier curves showing the association between retained CIED fragment and subsequent DVT (A, log-rank P = .003) and bloodstream infection (B, log-rank P = .622) [Color figure can be viewed at wileyonlinelibrary.com] patients due to the presence of the fragments. There were 5 patients who underwent MRI without adverse events. The feasibility and safety of MRI in patients with abandoned leads has been reported previously in nontransplanted and more recently in transplanted patients. 14 Nevertheless, careful monitoring is necessary given the relatively small number of patients exposed to MRI.
Heart transplant patients are exposed to 3.5 times more radiation than the general population, and the majority of this exposure comes from cardiac procedures. 15, 16 Patients having undergone transplantation are also at a higher risk for malignancies. 17 The and should be taken into account when evaluating our results.
Nevertheless the incidence of DVT in patients with fragments is significantly higher when compared with those without fragments and without CIED at baseline. Our radiation exposure measures are specific to our institution and recording software.
In summary there was a 16% prevalence of a retained cardiovascular implantable electronic device fragment after heart transplantation. Preventable factors associated with retained CIED fragments include the presence of abandoned leads and dual-coil ICD leads. Retained fragments encroaching into the SVC were associated with increased radiation exposure in subsequent biopsy procedures. Patients with retained fragments had a higher incidence of upper extremity DVT. Complete extraction of CIED fragments via surgical or transvenous approach may decrease the rate of upper extremity DVT and radiation exposure in heart transplant patients but further evaluation including prospective studies is needed.
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